[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341145-105":59,"doc-detail-341145-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-analysis-of-clinically-relevant-copy-number-alterations-cnas-using-a-523-gene-next-generation-sequencing-panel-and-nxclinical-software-in-solid-tumors","Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) - Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors","","Copy number alterations (CNAs) are central to tumor initiation, progression, and therapy resistance, making accurate identification essential for targeted treatments and personalized cancer diagnostics. A retrospective study assessed CNAs in 50 FFPE tumor samples across multiple solid tumor types using Illumina TruSight Oncology 500 (TSO500) and Affymetrix Oncoscan OS-MIP. NxClinical 6.2 NGS analysis showed 100% sensitivity and specificity with complete concordance versus OS-MIP, detecting all 54 known CNAs, with gains most frequent. Key CNAs were enriched in MYC, TP53, BRAF, and several oncogenes, supporting NxClinical reliability for clinically relevant CNA discovery to guide precision oncology strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-analysis-of-clinically-relevant-copy-number-alterations-cnas-using-a-523-gene-next-generation-sequencing-panel-and-nxclinical-software-in-solid-tumors/341145/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-clinically-relevant-copy-number-alterations-cnas-using-a-523-gene-next-generation-sequencing-panel-and-nxclinical-software-in-solid-tumors/341145.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the clinical importance of copy number alterations (CNAs) in cancer?","Question",{"text":112,"@type":113},"CNAs are significant in tumor initiation and progression and contribute to therapeutic resistance. Accurate CNA identification supports targeted therapies and personalized cancer diagnostics.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CNAs measured in this study?",{"text":117,"@type":113},"CNAs were evaluated in 50 FFPE tumor samples using Illumina TruSight Oncology 500 (TSO500) and Affymetrix Oncoscan OS-MIP, followed by NGS analysis with NxClinical 6.2 software.",{"name":119,"@type":110,"acceptedAnswer":120},"How accurate was NxClinical for CNA detection compared with OS-MIP?",{"text":121,"@type":113},"NxClinical demonstrated high sensitivity and specificity, with 100% performance for CNA detection and complete concordance compared to OS-MIP. All 54 known CNAs were identified.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341145,1791098169,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Article  \nComprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors  \nVivek Gupta 1,2,†, Vishakha Vashisht 2,†, Ashutosh Vashisht 2, Ashis K. Mondal 2, Ahmet Alptekin 2, Harmanpreet Singh 2 and Ravindra Kolhe 2, *  \nCitation: Gupta, V.; Vashisht, V.; Vashisht, A.; Mondal, A.K.; Alptekin, A.; Singh, H.; Kolhe, R. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene  \nNext-Generation Sequencing Panel and NxClinical Software in Solid Tumors. Genes 2024, 15, 396. [https://](https://)[ ](https://)[doi.org/10.3390/genes15040396](doi.org/10.3390/genes15040396)  \nAcademic Editor: Yutaka Suzuki  \nReceived: 16 February 2024  \nRevised: 18 March 2024  \nAccepted: 21 March 2024  \nPublished: 23 March 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 Department of Pathology, Government Institute of Medical Sciences, Greater Noida 201310, India; [dr_vivek_gupta@yahoo.com](dr_vivek_gupta@yahoo.com)  \n2 Department of Pathology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA; [vvashisht@augusta.edu](vvashisht@augusta.edu) (V.V.); [avashisht@augusta.edu](avashisht@augusta.edu) (A.V.); [amondal@augusta.edu](amondal@augusta.edu) (A.K.M.); [aalptekin@augusta.edu](aalptekin@augusta.edu) (A.A.); [hsingh1@augusta.edu](hsingh1@augusta.edu) (H.S.)  \n* Correspondence: [rkolhe@augusta.edu](rkolhe@augusta.edu)[ ](rkolhe@augusta.edu)† These authors contributed equally to this work.  \nAbstract: Copy number alterations (CNAs) are significant in tumor initiation and progression. Identifying these aberrations is crucial for targeted therapies and personalized cancer diagnostics. Next-generation sequencing (NGS) methods present advantages in scalability and cost-effectiveness, surpassing limitations associated with reference assemblies and probe capacities in traditional laboratory approaches. This retrospective study evaluated CNAs in 50 FFPE tumor samples (breast cancer, ovarian carcinoma, pancreatic cancer, melanoma, and prostate carcinoma) using Illumina’s TruSight Oncology 500 (TSO500) and the Affymetrix Oncoscan Molecular Inversion Probe (OS-MIP)(ThermoFisher Scientific, Waltham, MA, USA) . NGS analysis with the NxClinical 6.2 software demonstrated a high sensitivity and specificity (100%) for CNA detection, with a complete concordance rate as compared to the OS-MIP. All 54 known CNAs were identified by NGS, with gains being the most prevalent (63%) . Notable CNAs were observed in MYC (18%), TP53 (12%), BRAF (8%), PIK3CA, EGFR, and FGFR1 (6%) genes. The diagnostic parameters exhibited high accuracy, including a positive predictive value, negative predictive value, and overall diagnostic accuracy. This study underscores NxClinical as a reliable software for identifying clinically relevant gene alterations using NGS TSO500, offering valuable insights for personalized cancer treatment strategies based on CNA analysis.  \nKeywords: Copy Number Alterations; NxClinical Software; Next-Generation Sequencing; Molecular Inversion Probe; FFPE Solid Tumor  \n1. Introduction  \nGenomic instability, characterized by copy number alterations (CNAs), plays a pivotal role in cancer development and progression and in therapeutic resistance [1,2] . Amplifications and deletions within specific genomic segments can activate oncogenes or deactivate tumor suppressor genes, driving uncontrolled cell growth. Notably, solid tumors exhibit a heightened prevalence ofCNAs, emphasizing their significance in the context of solid tumor biology [3]. While various laboratory-based methods, such as multiplex liga","cbCaij85I2z1a1GI","https://ap.wps.com/l/cbCaij85I2z1a1GI","pdf",2563992,13,"English","# Introduction\n## Genomic instability and CNA significance in solid tumors\n## Limitations of traditional CNA detection methods\n## Challenges for CNA detection using NGS data\n## Bioinformatics tools for CNA calling and performance limits","[{\"question\":\"What is the clinical importance of copy number alterations (CNAs) in cancer?\",\"answer\":\"CNAs are significant in tumor initiation and progression and contribute to therapeutic resistance. Accurate CNA identification supports targeted therapies and personalized cancer diagnostics.\"},{\"question\":\"How were CNAs measured in this study?\",\"answer\":\"CNAs were evaluated in 50 FFPE tumor samples using Illumina TruSight Oncology 500 (TSO500) and Affymetrix Oncoscan OS-MIP, followed by NGS analysis with NxClinical 6.2 software.\"},{\"question\":\"How accurate was NxClinical for CNA detection compared with OS-MIP?\",\"answer\":\"NxClinical demonstrated high sensitivity and specificity, with 100% performance for CNA detection and complete concordance compared to OS-MIP. All 54 known CNAs were identified.\"}]","Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) - Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors | PDF",1790040551,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c215be42709c3487a9222ab446ae8d7.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/465920f1cf2fe6bec2266ec4a8ed4496.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0172de4174b390ba9e0938c4545f2a0.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/70a546c98edbae8ace7d7f4f4034a60f.webp",980,1385]